Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Current Assets: 2016-2019

Historic Current Assets for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $13.2 million.

  • Monopar Therapeutics' Current Assets rose 254.05% to $18.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $18.1 million, marking a year-over-year increase of 254.05%. This contributed to the annual value of $13.2 million for FY2019, which is 82.42% up from last year.
  • Per Monopar Therapeutics' latest filing, its Current Assets stood at $13.2 million for FY2019, which was up 82.42% from $7.3 million recorded in FY2018.
  • Monopar Therapeutics' 5-year Current Assets high stood at $13.2 million for FY2019, and its period low was $2.1 million during FY2016.
  • Its 3-year average for Current Assets is $9.9 million, with a median of $9.1 million in 2017.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 335.82% in 2017, then declined by 20.58% in 2018.
  • Yearly analysis of 4 years shows Monopar Therapeutics' Current Assets stood at $2.1 million in 2016, then skyrocketed by 335.82% to $9.1 million in 2017, then fell by 20.58% to $7.3 million in 2018, then surged by 82.42% to $13.2 million in 2019.